Abstract
Evaluating the real-world impact of first line PARP inhibitor maintenance therapy in patients with BRCA mutated ovarian tumors (1213)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.ygyno.2023.06.127
Copy DOIJournal: Gynecologic Oncology | Publication Date: Sep 1, 2023 |
Evaluating the real-world impact of first line PARP inhibitor maintenance therapy in patients with BRCA mutated ovarian tumors (1213)
Join us for a 30 min session where you can share your feedback and ask us any queries you have